Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

Published:2016-07-12 Issue:21 Volume:122 Page:3316-3326
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gaballa Sameh¹,Ge Isabell²,El Fakih Riad¹,Brammer Jonathan E.¹,Kongtim Piyanuch¹,Tomuleasa Ciprian¹,Wang Sa A.³,Lee Dean⁴,Petropoulos Demetrios⁴,Cao Kai⁵,Rondon Gabriela¹,Chen Julianne¹,Hammerstrom Aimee¹,Lombardi Lindsey¹,Alatrash Gheath¹,Korbling Martin¹,Oran Betul¹,Kebriaei Partow¹,Ahmed Sairah¹,Shah Nina¹,Rezvani Katayoun¹,Marin David¹,Bashir Qaiser¹,Alousi Amin¹,Nieto Yago¹,Qazilbash Muzaffar¹,Hosing Chitra¹,Popat Uday¹,Shpall Elizabeth J.¹,Khouri Issa¹,Champlin Richard E.¹,Ciurea Stefan O.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Houston Texas

2. University Medical Center Freiburg; Freiburg Germany

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Division of Pediatrics; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Laboratory Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30180/fullpdf

Reference30 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med.,2006

2. Impact of declining fertility rates in Canada on donor options in blood and marrow transplantation;Allan;Biol Blood Marrow Transplant.,2009

3. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available;Appelbaum;Hematology Am Soc Hematol Educ Program.,2008

4. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia;Saber;Blood.,2012

5. HLA match likelihoods for hematopoietic stem-cell grafts in the US registry;Gragert;N Engl J Med.,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus;Transplantation Proceedings;2024-09

2. Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning;Transplantation and Cellular Therapy;2024-05

3. Haploidentical vs Mismatched Unrelated Donor Transplants with Posttransplant Cyclophosphamide-based GVHD Prophylaxis;2024-02-16

4. Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioning;Transplant Immunology;2024-02

5. Haploidentical Hematopoietic Cell Transplantation;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024